United States· US:63941-708_d4796b2a-3796-47ac-be7f-8594ecfdb6a4
Best Choice Anti Nausea
A medicinal product containing dextrose, unspecified form; fructose; phosphoric acid, registered in United States by BEST CHOICE (VALU MERCHANDISERS COMPANY).
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID
- Manufacturer
- BEST CHOICE (VALU MERCHANDISERS COMPANY)
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1163941-708-04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe866a26-9011-462a-8350-b9479f755643 GET /v1/drugs/fe866a26-9011-462a-8350-b9479f755643?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1.87; 1.87; 21.5",
"substance": "DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID",
"productndc": "63941-708",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/5mL; g/5mL; mg/5mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about dextrose, unspecified form; fructose; phosphoric acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.